SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-19-005086
Filing Date
2019-03-15
Accepted
2019-03-15 17:27:57
Documents
105
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K navb20181231_10k.htm 10-K 2127118
2 EXHIBIT 21.1 ex_137466.htm EX-21.1 4952
3 EXHIBIT 23.1 ex_137467.htm EX-23.1 3723
4 EXHIBIT 24.1 ex_137468.htm EX-24.1 15168
5 EXHIBIT 31.1 ex_137469.htm EX-31.1 9074
6 EXHIBIT 32.1 ex_137470.htm EX-32.1 4470
13 f1.jpg GRAPHIC 7748
14 marcum.jpg GRAPHIC 10651
15 a1.jpg GRAPHIC 34957
  Complete submission text file 0001437749-19-005086.txt   11177856

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT navb-20181231.xml EX-101.INS 2149509
8 XBRL TAXONOMY EXTENSION SCHEMA navb-20181231.xsd EX-101.SCH 112480
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE navb-20181231_cal.xml EX-101.CAL 60710
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE navb-20181231_def.xml EX-101.DEF 903940
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE navb-20181231_lab.xml EX-101.LAB 674933
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE navb-20181231_pre.xml EX-101.PRE 926082
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35076 | Film No.: 19686081
SIC: 2835 In Vitro & In Vivo Diagnostic Substances